Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Thurlapati A"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Javaria Ahmad, Aswani Thurlapati, Sahith Thotamgari, Udhayvir Singh Grewal, Aakash Rajendra Sheth, Dipti Gupta, Kavitha Beedupalli, Paari Dominic
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundSeveral anti-cancer drugs have been linked to new onset atrial fibrillation (AF) but the true association of these drugs with AF is unknown. The FDA Adverse Event Reporting System (FAERS), a publicly available pharmacovigilance mechanism pr
Externí odkaz:
https://doaj.org/article/ae7fdefc4d3c4b59ba0877b907a75786
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Davis, James A., Thurlapati, Aswani, Weeda, Erin, Gaffney, Kelly J., Smith, Deidra, Maldonado, Andy, Granger, Katelynn, Martin, Kristy E., Williams, Yolanda M., Herrington, Taylor, Velayati, Arash, Bakos, Jonathan K., Green, Kimberly, Hashmi, Hamza
Publikováno v:
Annals of Hematology; Jan2024, Vol. 103 Issue 1, p251-258, 8p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kelly Gaffney, Jonathan Bakos, Arash Velayati, James Davis, Aswani Thurlapati, Erin Weeda, Andy Maldonado, Katelynn Granger, Coleen Butcher, Taylor Herrington, Deidra Smith, Kimberly Green, Brian Hess, Hamza Hashmi
Introduction: High-dose chemotherapy-autologous stem cell transplant (HDT-ASCT) improves both depth and duration of remission for patients with transplant-eligible newly diagnosed multiple myeloma (NDMM). Whether certain subgroups of NDMM derive the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f42004f4cd6aaf19fb4100c8cec3c31
https://doi.org/10.21203/rs.3.rs-2886938/v1
https://doi.org/10.21203/rs.3.rs-2886938/v1
Autor:
Thurlapati A; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC 29425, USA.; These authors contributed equally to the creation of the manuscript., Wesson W; University of Kansas School of Medicine, Kansas City, KS 66103, USA.; These authors contributed equally to the creation of the manuscript., Davis JA; Medical University of South Carolina College of Pharmacy, Charleston, SC 29425, USA., Gaffney KJ; Medical University of South Carolina College of Pharmacy, Charleston, SC 29425, USA., Weeda E; Medical University of South Carolina College of Pharmacy, Charleston, SC 29425, USA., Velayati A; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC 29425, USA., Bakos JK; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC 29425, USA., Granger K; Medical University of South Carolina College of Pharmacy, Charleston, SC 29425, USA., Smith D; Medical University of South Carolina College of Pharmacy, Charleston, SC 29425, USA., Maldonado AP; Medical University of South Carolina College of Pharmacy, Charleston, SC 29425, USA., Herrington T; Medical University of South Carolina College of Pharmacy, Charleston, SC 29425, USA., Potts J; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC 29425, USA., Hashmi H; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC 29425, USA.
Publikováno v:
Journal of hematology [J Hematol] 2023 Dec; Vol. 12 (6), pp. 243-254. Date of Electronic Publication: 2023 Dec 09.
Autor:
James A. Davis, Katelynn Granger, Kiera Roubal, Deidra Smith, Kelly J. Gaffney, Mary McGann, Alyssa Cendagorta, Aswani Thurlapati, Amanda Herbst, Lindsey Hendrickson, Hamza Hashmi, Brian T. Hess
Publikováno v:
Blood.
COVID-19 still represents a major issue for patients with lymphoid malignancies, especially those on therapy, because of immune suppression and suboptimal responses to vaccination. Davis et al report on their experience with double dose tixagevimab-c
Publikováno v:
Proc (Bayl Univ Med Cent)
Adult T-cell leukemia-lymphoma caused by human T-lymphotropic virus type 1 is a rare and aggressive tumor with high morbidity and mortality. Historically it has been treated with chemotherapy, but more recent studies suggest improvement in survival w